(Q50852041)

24 March 2018

http://europepmc.org/abstract/MED/9858229

title

No treatment for low-risk thrombocythaemia: results from a prospective study (English)

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

author name string

Ruggeri M

1

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

Finazzi G

2

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

Tosetto A

3

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

Riva S

4

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

Rodeghiero F

5

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

Barbui T

6

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

language of work or name

English

0 references

publication date

1 December 1998

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

published in

British Journal of Haematology

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

volume

103

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

issue

3

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

page(s)

772-777

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

cites work

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Essential thrombocythemias. Clinical evolutionary and biological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Outcome analysis of 34 pregnancies in women with essential thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Validated questionnaire for the identification of previous personal or familial venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Erythromelalgia: a clinical study of 87 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Essential thrombocythemia in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Clinical manifestations of essential thrombocythemia in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Hemostatic complications in young patients with essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation--a brief review of recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

Primary thrombocythemia: diagnosis, clinical manifestations and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.01021.X

10.1046/J.1365-2141.1998.01021.X

21 January 2018

Identifiers

DOI

1 reference

24 March 2018

http://europepmc.org/abstract/MED/9858229

1 reference

24 March 2018